Yahoo
NasdaqCM - Delayed Quote USD

NeuroSense Therapeutics Ltd. (NRSN)

1.9900 -0.1400 (-6.57%)
At close: October 30 at 4:00:00 PM EDT
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
--
-7,671
-10,135
-8,354
-7,616
Investing Cash Flow
--
-8
1
3,468
-3,590
Financing Cash Flow
--
4,432
10,913
3,975
3,774
End Cash Position
--
166
3,378
2,640
3,543
Capital Expenditure
--
-8
-3
-29
-70
Issuance of Capital Stock
--
4,531
11,304
4,334
0
Repayment of Debt
--
--
--
-80
-79
Free Cash Flow
--
-7,679
-10,138
-8,383
-7,686
12/31/2022 - 12/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: